Fundraising Fox

Biotech Investors & VC Firms in North America

272 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.

F-Prime Capital Partners
CambridgePre-Seed–Late Stage$3M – $10M
99 people
Andera Partners
ParisPre-Seed–Late Stage
130 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
60 people
Canaan Partners
StamfordPre-Seed–Series A$500K – $20M
29 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage
35 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M – $30M
23 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
82 people
8VC
AustinPre-Seed–Late Stage
65 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
42 people
Qiming Venture Partners
ShanghaiSeed–Growth$5M – $134M
5 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
23 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
44 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
72 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
99 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
76 people
Pillar VC
BostonPre-Seed–Series B$50K – $4M
61 people
OrbiMed
New YorkPre-Seed–Late Stage
22 people
HLM Venture Partners
BostonSeed–Late Stage$3M – $5M
32 people
HLM Investment Partners
BostonGrowth
33 people
Stifel Venture Banking
St. LouisSeed–Growth
75 people
Hyderabad Angels
HyderabadPre-Seed–Series A$60K – $480K
17 people
Birch Hill Equity Partners Management Inc.
TorontoGrowth–Late Stage$75M – $3B
67 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage
38 people
Paladin Capital Group
WashingtonSeed–Late Stage
65 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.